Namenda and Tacrolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Namenda (memantine hydrochloride) and Tacrolimus (tacrolimus). Common drug interactions include dizziness among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Namenda and Tacrolimus. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Namenda?

Namenda has active ingredients of memantine hydrochloride. It is often used in dementia. eHealthMe is studying from 14,283 Namenda users. Check the latest studies of Namenda.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

On Jul, 26, 2026

13 people who take Namenda and Tacrolimus together, and have interactions are studied.

Namenda and Tacrolimus drug interactions.

What are the common drug interactions of Namenda and Tacrolimus, by gender? *:

female:

Dizziness
Drug level increased
Fatigue (feeling of tiredness)
Flatulence (flatus expelled through the anus)
Insomnia (sleeplessness)
Nausea (feeling of having an urge to vomit)
Renal impairment (severely reduced kidney function)
Vision blurred

male:

Abdominal pain upper
Nausea (feeling of having an urge to vomit)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Drug hypersensitivity
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Pain in extremity
Skin exfoliation (removal of the oldest dead skin cells)
Syncope (loss of consciousness with an inability to maintain postural tone)
Unresponsive to stimuli
Drug ineffective

What are the common drug interactions of Namenda and Tacrolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Insomnia (sleeplessness)
Nausea (feeling of having an urge to vomit)
Renal impairment (severely reduced kidney function)
Vision blurred
Dizziness
Drug level increased
Fatigue (feeling of tiredness)
Flatulence (flatus expelled through the anus)

50-59:

n/a

60+:

Syncope (loss of consciousness with an inability to maintain postural tone)
Unresponsive to stimuli
Abdominal pain upper
Nausea (feeling of having an urge to vomit)
Bowen's disease (early stage of skin cancer)
Pain in extremity

What are the existing conditions these people have? *

Immunodeficiency Disorders: 6 people, 46.15%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 30.77%
Age-Related Macular Degeneration: 3 people, 23.08%
Gout (uric acid crystals building up in the body): 2 people, 15.38%
Atherosclerosis (disorder of the arteries): 2 people, 15.38%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 15.38%
Constipation: 2 people, 15.38%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 15.38%
Eye Haemorrhage (bleeding in the eye): 2 people, 15.38%
High Blood Cholesterol: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Namenda and Tacrolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously